Insulin resistance, hepatitis C, and liver transplantation.
Alsatie
Mazen
M
Pandya
Prashant
P
Chalasani
Naga P
NP
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000473:pathology / Q000503:physiopathology / Q000821:virology*; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000235:genetics / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007333:Insulin Resistance; D008103:Liver Cirrhosis / Q000473:pathology / Q000601:surgery / Q000821:virology; D016031:Liver Transplantation; D012367:RNA, Viral / Q000097:blood*; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D012367:RNA, Viral